Quintessence Biosciences, Inc.
3300 Commercial Avenue
Madison, Wisconsin 53714 USA
Phone: +1-608.441.2950
Fax: +1-608.441.2952
Main Image


Who is Quintessence Biosciences?

Quintessence Biosciences, Inc. is a biopharmaceutical company focused on development of novel protein-based therapeutics as anti-cancer agents. The Company’s products are based on the EVade™ Ribonuclease Technology which allows for the engineering of human proteins (ribonucleases) for the treatment of human diseases.

The EVade™ Ribonuclease technology is covered by patents acquired by the Company through an exclusive license with the University of Wisconsin. The Company has advanced lead candidate QBI-139 into a Phase I human clinical trial at the University of Wisconsin Comprehensive Cancer Center.Second generation products are under development and pre-clinical work is ongoing.
© 2015 Quintessence Biosciences, Inc. .
Home | About Us | Product Pipeline | Technology | News | Contact | Search